We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | NYSE:MRK | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.88 | -0.68% | 127.92 | 129.76 | 127.985 | 129.76 | 7,446,078 | 01:00:00 |
From May 2019 to May 2024
A Delaware jury ordered Gilead Sciences Inc. (GILD) to pay Merck & Co. (MRK) $2.54 billion of royalties in a patent lawsuit, Reuters reported Thursday.
The jury found a Merck patent on hepatitis C drugs was valid, the report said.
Full story at http://www.reuters.com/article/us-gilead-sciences-merck-co-verdict-idUSKBN1442U9
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
December 15, 2016 17:46 ET (22:46 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Merck Chart |
1 Month Merck Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
